- PMID: 38931353
- DOI: 10.3390/ph17060686
Abstract
Autism Spectrum Disorder (ASD) encompasses a wide range of neurodevelopmental conditions characterized by deficits in social interaction, communication and behavior. Current pharmacological options are limited and feature significant side effects. In this study, we conducted a retrospective, observational, and cross-sectional cohort study to evaluate the effects of Cannabidiol (CBD)-dominant, full-spectrum cannabis extract, containing Tetrahydrocannabinol (THC) in a ratio of 33:1 (CBD:THC), on non-syndromic children and adolescents (5-18 years old) with moderate to severe ASD. Thirty volunteers were recruited, underwent neuropsychological evaluations and were treated with individualized doses of CBD-dominant extract. Clinical assessments were conducted by the designated clinician. Additionally, parents or caregivers were independently interviewed to assess perceived treatment effects. We found significant improvements in various symptomatic and non-symptomatic aspects of ASD, with minimal untoward effects, as reported by both clinical assessments and parental perceptions. The observed improvements included increased communicative skills, attention, learning, eye contact, diminished aggression and irritability, and an overall increase in both the patient’s and family’s quality of life. Despite its limitations, our findings suggest that treatment with full-spectrum CBD-dominant extract may be a safe and effective option for core and comorbid symptoms of ASD, and it may also increase overall quality of life for individuals with ASD and their families.
Keywords: cannabinoid treatment, cannabis, idiopathic autism, pediatric neurodevelopmental disorders
Similar articles
-
Cannabinoid treatment for the symptoms of autism spectrum disorder.Expert Opin Emerg Drugs. 2024 Mar;29(1):65-79. doi: 10.1080/14728214.2024.2306290. Epub 2024 Jan 23.PMID: 38226593 Review.
-
Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms: a real-life report of multi-symptomatic benefits.Front Psychiatry. 2023 Aug 21;14:1210155. doi: 10.3389/fpsyt.2023.1210155. eCollection 2023.PMID: 37671290 Free PMC article.
-
Cannabidiol in Treatment of Autism Spectrum Disorder: A Case Study.Cureus. 2022 Aug 26;14(8):e28442. doi: 10.7759/cureus.28442. eCollection 2022 Aug.PMID: 36176817 Free PMC article.
-
CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature.J Cannabis Res. 2021 Dec 16;3(1):53. doi: 10.1186/s42238-021-00108-7.PMID: 34911567 Free PMC article. Review.
-
Effects of CBD-Enriched Cannabis sativa Extract on Autism Spectrum Disorder Symptoms: An Observational Study of 18 Participants Undergoing Compassionate Use.Front Neurol. 2019 Oct 31;10:1145. doi: 10.3389/fneur.2019.01145. eCollection 2019.PMID: 31736860 Free PMC article.